Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers

开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验

基本信息

  • 批准号:
    10427936
  • 负责人:
  • 金额:
    $ 18.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-15 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

(K.220) 7. Project Summary/Abstract Opioid use disorder (OUD) is associated with disproportionate deficits in the psychosocial determinants of health, with individuals exhibiting recovery capital (i.e. recovery resources) that is one standard deviation below that of other substance use disorders (SUDs) in the first year of recovery. OUD medications (MOUDs) are first-line treatments (Txs) that facilitate recovery by addressing the biophysiological disturbances caused by chronic opioid misuse. Yet, high rates of MOUD discontinuation and associated risks are ongoing concerns and, even when patients (Ps) are retained in Tx, psychosocial deficits often persist, increasing biobehavioral stress and hindering Tx/recovery. Thus, without a foundation of resources for recovery support/maintenance, current and former MOUD Ps are at ongoing risk for psychosocial impairment, which hinders recovery. The provision of recovery support services (RSS) offers one way to address extra-Tx needs and enhance recovery capital to ensure a safety net of resources and healthy coping skills to support MOUD Ps during and after Tx. Recovery Community Centers (RCCs) are a free, newly emerging, and rapidly growing tier of RSS that serve as ‘one-stop- shops’ for recovery capital, offering an array of services catered to the SUD community. RCCs seem to be especially well suited for MOUD Ps, as they operate under the maxim “many pathways [to recovery], all should be celebrated” (including MOUD), and the majority of RCC attendees have OUD and hold positive attitudes toward MOUD. Though early evidence suggests that RCCs can aid SUD recovery, its potential benefit to MOUD Ps has yet to be directly studied. Also, few MOUD Ps know of or use RCCs, and clinical linkage to them is uncommon. Thus, this 5-year project seek to advance our understanding of the clinical and public health utility of RCCs and help bridge the gap between clinical Tx and community-based RSS. As a first step in this work, we will develop and test a new intervention for peer-facilitated assertive linkage of MOUD Ps to RCCs (RCCL), relative to a matched control condition (CC). This study aims to: (1) develop, manualize, and refine RCCL/CC protocols via stakeholder feedback; (2) determine feasibility, acceptability, and preliminary efficacy (RCC attendance, service use, recovery capital) of RCCL vs. CC, via a pilot randomized controlled trial (RCT); (3) Gain in-depth insight to RCCL via qualitative interviews. This study will be the first to test RCCL for MOUD Ps, providing a foundation for larger-scale RCTs, with the potential to ultimately change clinical practice paradigms to address Ps’ extra-Tx needs and inform our ability to expand RCCL provision nationally. The aims support advanced training in: psychosocial determinants of health; RSS; intervention development/testing (via RCT); qualitative methods; ongoing OUD training, with a new focus on intervention research. Training will be fulfilled with expert guidance from Drs. John Kelly, Roger Weiss, Joanne Neale, David Best, Christine Timko, and Corrie Vilsaint. The training and experience provided by this award will serve as a critical foundation from which to build a an important and clinically relevant program of independent research.
(K.220)7。项目摘要/摘要 阿片类药物使用障碍(OUD)与健康的心理决定因素中的不足缺陷有关, 个人表现出恢复资本(即恢复资源),这是低于 在恢复的第一年,其他物质使用障碍(SUD)。 通过解决由慢性引起的生物生理障碍来促进恢复的治疗(TXS) 阿片类药物滥用。 当患者(PS)保留在TX中时,社会心理缺陷常常持续存在 因此,阻碍TX/恢复 前Moud PS正在进行心理社会障碍,这阻碍了康复 恢复支持服务(RSS)提供了一种满足超级TX需求并增强恢复资本的方法 确保资源和健康应对技巧的安全网,以支持TX期间和之后的MOUD PS 社区中心(RCC)是一个免费的,新兴的且迅速发展的RSS,它是一站式的 商店的恢复资本,提供适合SUD社区的一系列服务。 特别适合MOUD PS,因为它们在Maxim下运行“ [恢复]的许多途径 被庆祝”(包括穆德),大多数RCC与会者都拥有Oud protitiveatudestess 穆德(Moud)。 PS尚未直接研究。是IS是IS IS IS IS IS IS IS。 因此,这个五年的项目不常见 RCC并帮助弥合临床TX和基于社区的RS之间的差距。 将开发并测试对MOUD与RCCS(RCCL)的同伴相关的自信联系的新干预措施, 相对于匹配的控制条件(CC)。 通过利益相关者反馈的协议; RCCL与CC的出勤,服务使用,恢复资本,通过飞行员随机对照试验(RCT); 通过定性访谈深入了解RCCL。 为大型RCT提供基础,并有可能最终变化临床实践范例 满足PS的超级-TX需求,并为我们在全国范围内扩展RCCL提供的能力 高级培训:RSS的心理社会决定因素; 定性方法; 在John Kelly,Roger Weiss,Joanne Neal,David Best,Cristine Timko和Corrie的专家指导下 Vilsaint。 独立研究的重要且与临床相关的计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lauren A Hoffman其他文献

Lauren A Hoffman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lauren A Hoffman', 18)}}的其他基金

Developing and testing an intervention to enhance recovery capital amid opioid use disorder pharmacotherapy: A pilot randomized trial of assertive linkage to recovery community centers
开发和测试一种干预措施,以在阿片类药物使用障碍药物治疗中增强康复资本:与康复社区中心建立肯定联系的随机试点试验
  • 批准号:
    10590626
  • 财政年份:
    2022
  • 资助金额:
    $ 18.52万
  • 项目类别:
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients [SUPPLEMENT]
阿片类药物使用障碍、认知和恢复:丁丙诺啡和美沙酮治疗患者的神经心理变化和相关恢复结果的调查[补充]
  • 批准号:
    10405308
  • 财政年份:
    2022
  • 资助金额:
    $ 18.52万
  • 项目类别:
Opioid use disorder, cognition, and recovery: An investigation of neuropsychological change and associated recovery outcomes in buprenorphine and methadone treated patients
阿片类药物使用障碍、认知和恢复:丁丙诺啡和美沙酮治疗患者神经心理变化和相关恢复结果的调查
  • 批准号:
    10092146
  • 财政年份:
    2019
  • 资助金额:
    $ 18.52万
  • 项目类别:

相似国自然基金

坚持还是转型?反馈驱动的创业者机会信念认知更新及响应决策机理
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    45 万元
  • 项目类别:
    面上项目
不确定性下创业团队能量和抗逆力对创业坚持的权变影响研究
  • 批准号:
    72162025
  • 批准年份:
    2021
  • 资助金额:
    29 万元
  • 项目类别:
    地区科学基金项目
创造性思维中灵活性和坚持性动态交互的神经基础
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
科学基金应如何在国家创新体系中更好地坚持定位并充分发挥独特作用
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    60 万元
  • 项目类别:
    专项基金项目
企业坚持做慈善吗:企业持续捐赠特征及其成因与经济后果研究
  • 批准号:
    71402044
  • 批准年份:
    2014
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Applying Population Management Best Practices to Preventive Genomic Medicine
将人口管理最佳实践应用于预防性基因组医学
  • 批准号:
    10674202
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Applying Computational Phenotypes To Assess Mental Health Disorders Among Transgender Patients in the United States
应用计算表型评估美国跨性别患者的心理健康障碍
  • 批准号:
    10604723
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Development of a Video-based Personal Protective Equipment Monitoring System
基于视频的个人防护装备监控系统的开发
  • 批准号:
    10585548
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
Applying Deep Learning for Predicting Retention in PrEP Care and Effective PrEP Use among Key Populations at Risk for HIV in Thailand
应用深度学习预测泰国主要艾滋病毒高危人群中 PrEP 护理的保留情况以及 PrEP 的有效使用
  • 批准号:
    10619943
  • 财政年份:
    2023
  • 资助金额:
    $ 18.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了